Hepatology
From the Journals
NASH rapidly overtaking hepatitis C as cause of liver cancer
The analysis is based on National Health and Nutrition Examination Survey and the Organ Procurement and Transplantation Network data.
News
ACIP unanimously recommends HEPLISAV-B
ACIP includes HEPLISAV-B as a recommended vaccine against hepatitis B in adults.
From the Journals
Viremic suppression linked to decreased MACE rate in patients with HCV-cirrhosis
Viremic suppression was associated with a lower rate of cardiovascular events in patients with compensated HCV-related cirrhosis.
Feature
Liver cancer deaths expected to increase again in 2018
State estimates for this year put Utah and Hawaii at opposite ends of the mortality spectrum.
News from the FDA/CDC
Psychiatric issues common among hepatitis C inpatients
Comorbidities like drug abuse and psychoses present much more often in those with hepatitis C.
News
FDA adds boxed warning to obeticholic acid label
Data from required studies of the drug are expected in 2023.
News from the FDA/CDC
Baby boomers are the hepatitis C generation
Adults born before and after the boomers have much lower rates of hepatitis C–related hospitalizations.
Case Reports
Elevated serum alkaline phosphatase • generalized pruritus • Dx?
► Elevated serum alkaline phosphatase
► Generalized pruritus
Conference Coverage
Three in 10 of your diabetic patients may have liver fibrosis
LOS ANGELES – For every 10 of your adult patients with type 2 diabetes, three are likely to have moderate to severe liver fibrosis, according to...
From the Journals
Risks identified for drug-resistant bacteremia in cirrhosis
Prevalence of multidrug-resistant organism bacteremia was 33% in hospitalized patients with cirrhosis.
From the Journals
Amyloid depleter/antibody duo reduces systemic amyloidosis severity
Small, early clinical trial tests miridesap and dezamizumab.